GlassScriptPhysician profile
Mary J Bailey
NPI 1295953065
$1,407.60
in general payments reported to CMS, 2019-2025
16 companies · $291 in 2025
The $291 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $12.84 · 2021: $134 · 2022: $180 · 2023: $315 · 2024: $294 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $311.63 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $270.71 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $209.48 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Novo Nordisk INC | $186.23 | 2019-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $133.22 | 2024-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.60 | 2019-2022 | |
| Pfizer INC. | $40.45 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $39.09 | 2021 | |
| Collegium Pharmaceutical, INC. | $36.31 | 2025 | Jornay Pm |
| Rhythm Pharmaceuticals, INC. | $25.84 | 2023 | Imcivree |
| Abbott Laboratories | $19.72 | 2023 | Freestyle Libre 3 |
| Boston Scientific Corporation | $18.63 | 2025 | Embold Fibered |
| Seqirus USA INC | $16.65 | 2024 | Flucelvax |
| Otsuka America Pharmaceutical, INC. | $16.03 | 2022 | |
| Amgen INC. | $15.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.